Giancarlo CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Ecco i finalisti del Premio Roma di letteratura - Il Faro Online
Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer
Giancarlo Antonini (@gcarloantonini) / Twitter
ioo;;-~~ ." - ,
Untitled
Genomic Classification of Cutaneous Melanoma - University of Miami
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn
Frontiers | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
7 perfiles de «Carlo Cappellini» | LinkedIn
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with T
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Giancarlo Antonini (@gcarloantonini) / Twitter
Frontiers | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Immunological validation of α2MB, Apo E and Apo A1 as potential diagnostic biomarkers.
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with T
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
![PDF] Mutational Profile of Driver Genes in Brazilian Melanomas by Anna Luiza Silva Almeida Vicente, Camila Crovador, Graziela Macedo, Cristovam Scapulatempo-Neto, Rui L. Reis, Vinicius de Lima Vazquez · OA.mg · 10.1200/jgo.19.00169](https://og.oa.mg/Mutational%20Profile%20of%20Driver%20Genes%20in%20Brazilian%20Melanomas.png?author=%20Anna%20Luiza%20Silva%20Almeida%20Vicente,%20Camila%20Crovador,%20Graziela%20Macedo,%20Cristovam%20Scapulatempo-Neto,%20Rui%20L.%20Reis,%20Vinicius%20de%20Lima%20Vazquez "PDF] Mutational Profile of Driver Genes in Brazilian Melanomas by Anna Luiza Silva Almeida Vicente, Camila Crovador, Graziela Macedo, Cristovam Scapulatempo-Neto, Rui L. Reis, Vinicius de Lima Vazquez · OA.mg · 10.1200/jgo.19.00169")
PDF] Mutational Profile of Driver Genes in Brazilian Melanomas by Anna Luiza Silva Almeida Vicente, Camila Crovador, Graziela Macedo, Cristovam Scapulatempo-Neto, Rui L. Reis, Vinicius de Lima Vazquez · OA.mg · 10.1200/jgo.19.00169
Dr. Michael A. Davies, MD | Houston, TX | Oncologist | US News Doctors
ioo;;-~~ ." - ,
Giancarlo Antonini (@gcarloantonini) / Twitter
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
